The findings of the research team led by Dr. Charles Fuchs of the Dana-Farber Cancer Institute and Harvard School of Public Health confirm a small but growing body of evidence that dietary and behavioral changes can reduce the risk of some cancers in people who may have an inherited tendency to develop them.

“Previous research has demonstrated that people’s risk of developing colon cancer is two times greater if they have a parent or sibling who has been diagnosed with the disease,” Fuchs said in a prepared statement. “Our study points to steps that such individuals can take to substantially lower those odds.”

The study, published in the March issue of Cancer Epidemiology, Biomarkers and Prevention, draws from data collected in the Nurses’ Health Study, a project which has been tracking the health of 121,700 female registered nurses in the United States for more than 25 years.

The study, run by researchers at Brigham and Women’s Hospital, maintains an extensive databank of participants’ dietary and lifestyle habits, making it possible to explore the relation between people’s behavior and their risk of developing certain diseases.

In this new study researchers analyzed information from 88,758 nurses whose family health histories and dietary habits were recorded in the database. Fuchs and his colleagues focused on behaviors known to be associated with colon cancer such as smoking, eating a diet high in fruits and vegetables, avoiding heavy red meat consumption, and having regular colon exams after age 50.

Fuchs asked whether any of these measures are especially effective in people with a family history of the disease.

They found that a diet high in folic acid, high in methionine (an essential amino acid), and low in alcohol intake, when followed at least five years, reduced colon cancer risk much more sharply in those with first-degree relatives who had the disease than in those without such a family history.

Participants with a family history of colorectal cancer who consumed low-folate diets were 2.5 times more likely to develop colon cancer than similar individuals who did not have a family history. In contrast, among participants on a high-folate diet, those with a family pattern of colorectal cancer did not experience any significant increase in colon cancer risk compared to those without such a pattern.

“It appeared that either a high-folate diet or use of folate-containing multivitamins virtually eliminated the excess risk of colon cancer associated with a family history of the disease,” says Fuchs, who is also on staff at Brigham and Women’s Hospital and an assistant professor of medicine at Harvard Medical School.

Although all the study participants were women, Fuchs contends there’s no reason to think the results do not apply to men as well.

Folic acid is found in fruits and vegetables and products made with enriched flour. Obtaining the high levels (400 micrograms a day) tracked in the study can be easily achieved by taking a multivitamin, Fuchs says. The quantity of alcohol consumption that appeared to increase the risk associated with a family history was greater than two glasses of wine per day.

The findings around methionine are more complicated. While high levels of the nutrient were shown to reduce the influence of a family history of colorectal cancer on the development of the disease, high amounts also may be associated with the “hardening of the arteries” that can lead to heart attacks. As a result, dieticians do not recommend taking methionine supplements.

The new study not only provides guidance to people with family risks of colon cancer, Fuchs says, but also may point toward a better understanding of the biology of the disease. Scientists know that folic acid, methionine, and alcohol all affect a process known as “methylation,” in which specialized compounds of hydrogen and carbon are attached to various structures and products of cells.

Methylation plays a vital role, for example, in creating the building blocks of DNA within cells. Without sufficient methylation, the DNA structure may become unstable, raising the prospect of certain diseases, including cancer.

It’s possible, Fuchs says, that families with a pattern of colon cancer may have some modest alteration in either DNA processing or repair that makes them particularly susceptible to deficiencies in the methylation process.

With approximately 135,000 new cases reported each year, colon cancer is the third most commonly diagnosed cancer in the United States, and it is one of the leading causes of cancer-related deaths.

Copyright © 2001 NexCura, Inc. All rights reserved. Republication or redistribution of cancerfacts.com content, including by framing or similar means, is expressly prohibited without the prior written consent of NexCura. NexCura and cancerfacts.com are trademarks of NexCura, Inc. or its affiliates. Copyright © 2001. This information is for educational purposes only.